(Q51556998)
Statements
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes. (English)
1 reference
Raskin P
1 reference
Rappaport EB
1 reference
Cole ST
1 reference
Yan Y
1 reference
Patwardhan R
1 reference
Freed MI
1 reference
1 March 2000
1 reference
43
1 reference
3
1 reference
278-284
1 reference